Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Aducanumab Approval Decision Delayed: What’s In The Major Amendment?
Jan 29 2021
•
By
Mandy Jackson
The US FDA requested more information on aducanumab and then delayed its approval decision until 7 June • Source: Shutterstock
More from Product Reviews
More from Pink Sheet